ANEW Medical Debt to Equity Ratio 2023-2024 | KLTO
Current and historical debt to equity ratio values for ANEW Medical (KLTO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ANEW Medical debt/equity for the three months ending June 30, 2024 was 0.00.
| ANEW Medical Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-06-30 |
$0.00B |
|
0.00 |
| 2022-03-31 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.015B |
$0.000B |
|
ANEW MEDICAL INC. specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The company's focus on central nervous systems diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease, dementia symptoms and neuromuscular diseases. ANEW MEDICAL INC., formerly known as REDWOODS ACQ, is based in NEW YORK.
|
